RJT
Raymond James Trust Portfolio holdings
AUM
$4.6B
1-Year Return
33.54%
This Quarter Return
+6.82%
1 Year Return
+33.54%
3 Year Return
+41.34%
5 Year Return
+111.31%
10 Year Return
+235.23%
AUM
$3.01B
AUM Growth
+$141M
(+4.9%)
Cap. Flow
-$39.3M
Cap. Flow
% of AUM
-1.3%
Top 10 Holdings %
Top 10 Hldgs %
19.44%
Holding
1,183
New
90
Increased
402
Reduced
504
Closed
59
Top Buys
| 1 |
Equifax
EFX
|
$4.49M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$3.2M |
| 3 |
Abbott
ABT
|
$3.02M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$2.94M |
| 5 |
AbbVie
ABBV
|
$2.74M |
Top Sells
| 1 |
Coca-Cola
KO
|
$15.4M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$12.4M |
| 3 |
Meta Platforms (Facebook)
META
|
$4.85M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$3.71M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$3.65M |
Sector Composition
| 1 | Technology | 16.21% |
| 2 | Financials | 10.91% |
| 3 | Healthcare | 9.71% |
| 4 | Consumer Staples | 7.25% |
| 5 | Industrials | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Invesco Total Return Bond ETF
GTO
$1.92B
| $2.03M | 0.07% |
+35,627
| New | +$2.03M |
|
252
AstraZeneca
AZN
$253B
| $2.02M | 0.07% |
33,708
+1,773
| +6% | +$106K |
|
253
IQVIA
IQV
$31.9B
| $2M | 0.07% |
8,252
-262
| -3% | -$63.5K |
|
254
First Trust Value Line Dividend Fund
FVD
$9.15B
| $2M | 0.07% |
50,240
+1,419
| +3% | +$56.4K |
|
255
ASML
ASML
$307B
| $1.97M | 0.07% |
2,853
+209
| +8% | +$144K |
|
256
Nutrien
NTR
$27.4B
| $1.96M | 0.07% |
32,355
-539
| -2% | -$32.7K |
|
257
GSK
GSK
$81.5B
| $1.96M | 0.07% |
39,298
-1,330
| -3% | -$66.2K |
|
258
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $1.96M | 0.07% |
22,685
-97
| -0.4% | -$8.36K |
|
259
iShares Gold Trust
IAU
$52.6B
| $1.95M | 0.06% |
57,844
+39
| +0.1% | +$1.32K |
|
260
SPDR Gold Trust
GLD
$112B
| $1.93M | 0.06% |
11,660
+925
| +9% | +$153K |
|
261
Invesco Preferred ETF
PGX
$3.93B
| $1.89M | 0.06% |
123,648
+42,752
| +53% | +$655K |
|
262
Novartis
NVS
$251B
| $1.89M | 0.06% |
20,694
-9,276
| -31% | -$846K |
|
263
Baxter International
BAX
$12.5B
| $1.89M | 0.06% |
23,447
-481
| -2% | -$38.7K |
|
264
JPMorgan Ultra-Short Income ETF
JPST
$33B
| $1.87M | 0.06% |
36,852
+13,790
| +60% | +$700K |
|
265
O'Reilly Automotive
ORLY
$89B
| $1.86M | 0.06% |
49,335
+10,410
| +27% | +$393K |
|
266
First Trust Rising Dividend Achievers ETF
RDVY
$16.5B
| $1.83M | 0.06% |
38,128
+14,448
| +61% | +$694K |
|
267
Teladoc Health
TDOC
$1.38B
| $1.82M | 0.06% |
10,971
-34
| -0.3% | -$5.65K |
|
268
S&P Global
SPGI
$164B
| $1.82M | 0.06% |
4,433
+161
| +4% | +$66.1K |
|
269
Regions Financial
RF
$24.1B
| $1.82M | 0.06% |
90,108
-2,039
| -2% | -$41.1K |
|
270
Vanguard Small-Cap Growth ETF
VBK
$20.4B
| $1.81M | 0.06% |
6,229
-142
| -2% | -$41.1K |
|
271
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.6B
| $1.78M | 0.06% |
175,997
+7,347
| +4% | +$74.4K |
|
272
Goldman Sachs
GS
$223B
| $1.78M | 0.06% |
4,695
-2,149
| -31% | -$816K |
|
273
Charles Schwab
SCHW
$167B
| $1.74M | 0.06% |
23,909
-157
| -0.7% | -$11.4K |
|
|
INFO
274
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $1.73M | 0.06% |
15,383
-179
| -1% | -$20.2K |
|
275
Synchrony
SYF
$28.1B
| $1.71M | 0.06% |
35,325
-4,543
| -11% | -$220K |
|